Literature DB >> 27496976

Infection-Induced Vascular Permeability Aids Mycobacterial Growth.

Stefan H Oehlers1,2,3, Mark R Cronan1, Rebecca W Beerman1, Matthew G Johnson4, Jianhua Huang4, Christopher D Kontos4, Jason E Stout4, David M Tobin1,5.   

Abstract

Pathogenic mycobacteria trigger formation of organized granulomas. As granulomas mature, they induce angiogenesis and vascular permeability. Here, in a striking parallel to tumor pro-angiogenic signaling, we identify angiopoietin-2 (ANG-2) induction as an important component of vascular dysfunction during mycobacterial infection. Mycobacterial infection in humans and zebrafish results in robust induction of ANG-2 expression from macrophages and stromal cells. Using a small-molecule inhibitor closely related to one currently in clinical trials, we link ANG-2/TIE2 signaling to vascular permeability during mycobacterial infection. Targeting granuloma-induced vascular permeability via vascular endothelial-protein tyrosine phosphatase inhibition limits mycobacterial growth, suggesting a new strategy for host-directed therapies against tuberculosis.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Mycobacterium tuberculosis; TIE2; VE-PTP; angiopoietin; granuloma; vascular permeability; zebrafish

Mesh:

Substances:

Year:  2017        PMID: 27496976      PMCID: PMC5853473          DOI: 10.1093/infdis/jiw355

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.

Authors:  Jikui Shen; Maike Frye; Bonnie L Lee; Jessica L Reinardy; Joseph M McClung; Kun Ding; Masashi Kojima; Huiming Xia; Christopher Seidel; Raquel Lima e Silva; Aling Dong; Sean F Hackett; Jiangxia Wang; Brian W Howard; Dietmar Vestweber; Christopher D Kontos; Kevin G Peters; Peter A Campochiaro
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

2.  Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2.

Authors:  G Fachinger; U Deutsch; W Risau
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

Review 3.  Targeting the ANGPT-TIE2 pathway in malignancy.

Authors:  Hanhua Huang; Abhijit Bhat; Gary Woodnutt; Rodney Lappe
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

4.  Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish.

Authors:  Koji Ando; Shigetomo Fukuhara; Nanae Izumi; Hiroyuki Nakajima; Hajime Fukui; Robert N Kelsh; Naoki Mochizuki
Journal:  Development       Date:  2016-03-07       Impact factor: 6.868

5.  Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.

Authors:  Shom Goel; Nisha Gupta; Brian P Walcott; Matija Snuderl; Cristina T Kesler; Nathaniel D Kirkpatrick; Takahiro Heishi; Yuhui Huang; John D Martin; Eleanor Ager; Rekha Samuel; Shuhan Wang; John Yazbek; Benjamin J Vakoc; Randall T Peterson; Timothy P Padera; Dan G Duda; Dai Fukumura; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2013-07-30       Impact factor: 13.506

Review 6.  Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.

Authors:  Wei-Xiang Qi; Zan Shen; Li-Na Tang; Yang Yao
Journal:  Crit Rev Oncol Hematol       Date:  2014-05-02       Impact factor: 6.312

7.  Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammation.

Authors:  Catherine T K Le; Grace Laidlaw; Christopher A Morehouse; Brian Naiman; Philip Brohawn; Tomas Mustelin; Jane R Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2015-09-05       Impact factor: 4.307

Review 8.  The immunological life cycle of tuberculosis.

Authors:  Joel D Ernst
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

9.  Interception of host angiogenic signalling limits mycobacterial growth.

Authors:  Stefan H Oehlers; Mark R Cronan; Ninecia R Scott; Monica I Thomas; Kazuhide S Okuda; Eric M Walton; Rebecca W Beerman; Philip S Crosier; David M Tobin
Journal:  Nature       Date:  2014-11-24       Impact factor: 49.962

10.  Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.

Authors:  Stefanie Gurnik; Kavi Devraj; Jadranka Macas; Maiko Yamaji; Julia Starke; Alexander Scholz; Kathleen Sommer; Mariangela Di Tacchio; Rajkumar Vutukuri; Heike Beck; Michel Mittelbronn; Christian Foerch; Waltraud Pfeilschifter; Stefan Liebner; Kevin G Peters; Karl H Plate; Yvonne Reiss
Journal:  Acta Neuropathol       Date:  2016-03-01       Impact factor: 17.088

View more
  16 in total

1.  Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.

Authors:  Elinor Hortle; Khelsey E Johnson; Matt D Johansen; Tuong Nguyen; Jordan A Shavit; Warwick J Britton; David M Tobin; Stefan H Oehlers
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

2.  Inhibition of infection-induced vascular permeability modulates host leukocyte recruitment to Mycobacterium marinum granulomas in zebrafish.

Authors:  Julia Y Kam; Tina Cheng; Danielle C Garland; Warwick J Britton; David M Tobin; Stefan H Oehlers
Journal:  Pathog Dis       Date:  2022-04-29       Impact factor: 3.951

Review 3.  Illuminating Macrophage Contributions to Host-Pathogen Interactions In Vivo: the Power of Zebrafish.

Authors:  Emily E Rosowski
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

4.  Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling.

Authors:  Eric M Walton; Mark R Cronan; C J Cambier; Andrea Rossi; Michele Marass; Matthew D Foglia; W Jared Brewer; Kenneth D Poss; Didier Y R Stainier; Carolyn R Bertozzi; David M Tobin
Journal:  Cell Host Microbe       Date:  2018-10-10       Impact factor: 21.023

5.  Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.

Authors:  Henna Myllymäki; Mirja Niskanen; Hanna Luukinen; Mataleena Parikka; Mika Rämet
Journal:  Dis Model Mech       Date:  2018-03-13       Impact factor: 5.758

6.  Neutrophil derived LTB4 induces macrophage aggregation in response to encapsulated Streptococcus iniae infection.

Authors:  William J B Vincent; Elizabeth A Harvie; John-Demian Sauer; Anna Huttenlocher
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

7.  A Modular Microscale Granuloma Model for Immune-Microenvironment Signaling Studies in vitro.

Authors:  Samuel B Berry; Maia S Gower; Xiaojing Su; Chetan Seshadri; Ashleigh B Theberge
Journal:  Front Bioeng Biotechnol       Date:  2020-08-18

Review 8.  Mycobacterial Evolution Intersects With Host Tolerance.

Authors:  Joseph W Saelens; Gopinath Viswanathan; David M Tobin
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 9.  Host-directed therapies for bacterial and viral infections.

Authors:  Stefan H E Kaufmann; Anca Dorhoi; Richard S Hotchkiss; Ralf Bartenschlager
Journal:  Nat Rev Drug Discov       Date:  2017-09-22       Impact factor: 84.694

10.  Mycobacteria employ two different mechanisms to cross the blood-brain barrier.

Authors:  Lisanne M van Leeuwen; Maikel Boot; Coen Kuijl; Daisy I Picavet; Gunny van Stempvoort; Susanne M A van der Pol; Helga E de Vries; Nicole N van der Wel; Martijn van der Kuip; A Marceline van Furth; Astrid M van der Sar; Wilbert Bitter
Journal:  Cell Microbiol       Date:  2018-05-30       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.